alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.2

          CERTIFICATION PURSUANT TO RULE 13a-14(a) OF THE EXCHANGE ACT

I, David Blechman, Treasurer of IBX Group, Inc. certify that:

1. I have reviewed this quarterly report on Form 10-QSB of IBX Group, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

   a) designed such disclosure controls and procedures or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this quarterly report is being prepared;

   b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
quarterly report (the "Evaluation Date"); and

   c) presented in this quarterly report our conclusions about the effectiveness
of the disclosure controls and procedures based on our evaluation as of the
Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):

   a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and

   b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and

6. The registrant's other certifying officers and I have indicated in this
quarterly report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal controls
subsequent to the date of our most recent evaluation, including any corrective
actions with regard to significant deficiencies and material weaknesses.

Date: November 14, 2003               /s/ David Blechman
                                      -------------------------
                                      David Blechman, Treasurer
<PAGE>
                                                                      Exhibit 32

      CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that the Report of Argonaut Technologies,
Inc. on Form 10-K for the period ended December 31, 2003 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and that information contained in such Report fairly presents in all material
respects the financial condition and results of operations of Argonaut
Technologies, Inc.

Date: March 30, 2004

                            By:  /S/ LISSA A. GOLDENSTEIN
                              -------------------------------------
                            Name:  Lissa A. Goldenstein
                            Title: President, Chief Executive Officer


                            By:  /S/ DAVID J. FOSTER
                              --------------------------------
                            Name:  David J. Foster
                            Title: Sr. Vice President, Chief Financial Officer
Krista Marie TAYLOR, Appellant, v. DEPARTMENT OF REVENUE O/B/O Jack Grayson LOONEY, Appellee.

Case No. 5D18-2411

District Court of Appeal of Florida, Fifth District.

Opinion filed December 21, 2018

Krista Marie Taylor, Ocala, pro se.

Pamela Jo Bondi, Attorney General, and Toni C. Bernstein, Senior Assistant Attorney General, Office of the Attorney General Child Support Division, Tallahassee, for Appellee.

PER CURIAM.

A trial court's decision comes before the appellate court with a presumption of correctness. *Applegate v. Barnett Bank of Tallahassee* , 377 So.2d 1150, 1152 (Fla. 1979). Here, without a hearing transcript or proper substitute, Appellant is unable to meet her burden to demonstrate error. *Id.*

AFFIRMED.

EVANDER, EDWARDS and HARRIS, JJ., concur.
EXHIBIT
10.3


 


DEMAND PROMISSORY NOTE


 


 


	
  $225,809.49

  	
   

  	
  Due:  June 15, 2004

  



 


For value received, the
undersigned, Lee Pharmaceuticals (the “Borrower”), hereby acknowledges itself
indebted to Henry L. Lee, Jr. (the “Lender”) and promises to pay on demand to
or to the order of the Lender, at South El Monte, California, or as otherwise
directed in writing by the Lender, the principal sum of $225,809.49 with
interest thereon at the rate of 12% per annum, compounded monthly, based on a
365-day year, actual day month.


 


The Lender may assign all
of his right, title and interest in, to and under this demand promissory
note.  All payments required to be made
hereunder shall be made by the Borrower without any right of set off or counterclaim.


 


The Demand Promissory
Note shall be governed by and interpreted in accordance with the laws of the
State of California.  This note is
unsecured.


 


 


	
  JUNE 15, 2004

  	
   

  	
  RONALD G. LEE

  	
   

  
	
   

  	
  Lee Pharmaceuticals by
  Ronald G. Lee

  
	
   

  	
  President

  
	
   

  	
   

  
	
   

  	
   

  
	
  JUNE 15, 2004

  	
   

  	
  MICHAEL L. AGRESTI

  	
   

  
	
   

  	
  Lee Pharmaceuticals by
  Michael L. Agresti

  
	
   

  	
  Vice President -
  Finance
## Breadcrumb

-  Home 

# Explore Search: Extreme Events

Filters

              - science_science(148)
              - products_data(13)
              - products_publications(237)
              - products_web_tools(1)
              - multimedia_audio(41)
              - multimedia_audio-141766(35)
              - multimedia_audio-141767(6)
              - multimedia_image(21)
              - (-)multimedia_image-141771(16)
              - multimedia_image-141774(1)
              - multimedia_image-141775(1)
              - multimedia_image-141776(3)
              - multimedia_video(151)
              - multimedia_video-149194(96)
              - multimedia_video-149195(31)
              - multimedia_video-149196(2)
              - multimedia_video-149197(8)
              - multimedia_video-149198(1)
              - multimedia_video-149225(2)
              - documents_file(1)
              - documents_file-149210(1)
              - news_news-149245(2)
              - news_news-149248(1)
              - news_news-149250(1)
              - news_other_news(10)
              - connect_staff_profiles(3)
              - other_basic-42(7)

## By Location

              - california(3)
              - florida(1)
              - georgia(1)
              - oregon(1)
              - south dakota(2)

## By Year

Photography        April 12, 2018        USGS Scientists at Capitol Hill Roundtable on Extreme Events

Photography        July 26, 2019        Dr. Tom Kwak, Dr. Gus Engman, Ámbar Torres Molinari, and Bonnie Myers

Photography        August 2, 2018        Tuolumne watershed landslides

Photography        December 31, 2023        Tarah Balden, scientist, Yurok Tribe looking at data logger

Photography        April 26, 2023        Rapid erosion of hillsides along the Rio Coca in Ecuador after collapse of a lava dam.

Photography        April 26, 2023        Streambank erosion on the Rio Coca after a waterfall collapse, Ecuador.

Photography        April 27, 2023        Molly Wood at a viewpoint on the Rio Coca, Ecuador, where substantial erosion and landslides have occurred

Photography        April 26, 2023        Regressive erosion on the Rio Coca upstream of the former San Rafael waterfall site, Ecuador

Photography        April 26, 2023        Sediment and flow monitoring station on the Rio Quijos, Rio Coca watershed, Ecuador

Photography        April 1, 2016        Laysan Albatross with chick in Kauai

Photography        October 21, 2016        Sunset at Sage Lot Pond Salt Marsh Observatory

Photography        July 19, 2018        Verification of Reference Elevations at USGS streamgage in SD

Photography        July 19, 2018        Reading Elevation of a Known Reference Point in SD

Photography        September 21, 2020        Madeira Beach Camera Time Series

Photography        September 21, 2009        USGS scientists measuring Sept. 2009 flooding, Powder Springs Cr, GA

Photography        November 19, 2020        Sunset State Beach Variance Image
**Exhibit32**

 

**CERTIFICATIONPURSUANT TO**

**18U.S.C. SECTION 1350,**

**ASADOPTED PURSUANT TO**

**SECTION906 OF THE SARBANES-OXLEY ACT OF 2002**

 

Pursuant to Section 906of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies that thisperiodic report fully complies with the requirements of section 13(a) or 15(d)of the Securities Exchange Act of 1934 and that information contained in thisperiodic report fairly presents, in all material respects, the financialcondition and results of RadView Software Ltd.

 
| Date: November 12, 2004 |                                                 |
|-------------------------|------------------------------------------------------|
|                    | /s/ ILAN KINREICH                                    |   |
|                    | Ilan Kinreich  President and Chief Executive Officer |
|                    |                                                 |
| Date: November 12, 2004 |                                                 |
|                    | /s/ CHRISTOPHER DINEEN                               |   |
|                    | Christopher Dineen  Chief Financial Officer          |

 

The foregoingcertification if being furnished solely to accompany the Report pursuant to 18U.S.C. Section 1350 and is not being filed under the Securities Exchange Act of1934, as amended, and is not to be incorporated by reference into any filing ofthe Company after the date hereof, regardless of any general incorporationlanguage in such filing.

 

----
EX-10.1









Exhibit 10.1




Description of Fiscal 2009 Annual Incentive Plan




          On May 28, 2008, the Compensation Committee (the “Committee”) of the Board of Directors (the
“Board”) of Black Box Corporation (the “Company”) recommended that the Board approve, and the Board
approved, an annual incentive bonus plan (the “Annual Incentive Plan”) for the fiscal year ending
March 31, 2009. The performance goals for the Annual Incentive Plan are operating earnings per
share, adjusted operating income as a percentage of total revenues, adjusted EBITDA (“Adjusted
EBITDA”) and DSOs (as each of those measurements is determined consistent with the Company’s press
release dated May 22, 2008 filed as an exhibit to the Company’s Current Report on Form 8-K for the
event dated May 22, 2008). The performance goals will be equally weighted. Under the Annual
Incentive Plan, the achievement of the performance goals at approximately 90% of target will result
in a payout of 50% of targeted annual bonus, the achievement of the performance goals at 100% of
target will result in a payout of 100% of targeted annual bonus and the achievement of the
performance goals at approximately 110% of target will result in a payout of 150% of targeted
annual bonus. Following Board review and approval, the Committee made targeted annual bonus awards
under the Annual Incentive Plan to the Company’s executive officers as follows: R. Terry
Blakemore, President and Chief Executive Officer -- 100% of base salary or $550,000; Michael
McAndrew, Vice President, Chief Financial Officer, Treasurer and
Secretary -- 80% of base salary or
$252,000; and Francis W. Wertheimber, Senior Vice President -- 50% of base salary or $132,500.
---

EXHIBIT 31.2

I, Marcel Urbanc, chief financial officer and principal accounting officer of
AlphaRx, Inc. certify that:

1. I have reviewed this quarterly report on Form 10QSB of AlphaRx, Inc.;

2. Based on my knowledge, this quarterly report does not
contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by
this quarterly report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
registrant and have:

> a) designed such disclosure controls and procedures to ensure that material
>   information relating to the registrant, including its consolidated
>   subsidiaries, is made known to me by others within those entities,
>   particularly during the period in which this quarterly report is being
>   prepared;
>   b) evaluated the effectiveness of the registrant's disclosure controls and
>   procedures as of a date within 90 days prior to the filing date of this
>   quarterly report (the "Evaluation Date"); and
>   c) presented in this quarterly report my conclusions about the
>   effectiveness of the disclosure controls and procedures based on my evaluation
>   as of the Evaluation Date;

5. We have disclosed, based on my most recent evaluation, to the registrant's
auditors and the audit committee of registrant's board of directors (or persons
performing the equivalent functions):

> a) all significant deficiencies in the design or operation of internal
>   controls which could adversely affect the registrant's ability to record,
>   process, summarize and report financial data and have identified for the
>   registrant's auditors any material weaknesses in internal controls; and
>   b) any fraud, whether or not material, that involves management or other
>   employees who have a significant role in the registrant's internal controls;
>   and

6. I have indicated in this quarterly report whether there
were significant changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of my most recent
evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.

/s/ Marcel UrbancMarcel Urbanc 
Chief Financial Officer and Principal Accounting Officer 
August 14, 2006

---
Anderson Paul HARRIS, Appellant, v. STATE of Florida, Appellee.

Case No. 5D17-3118

District Court of Appeal of Florida, Fifth District.

Decision filed December 18, 2018

James S. Purdy, Public Defender, and Sean Kevin Gravel and Robert E. Wildridge, Assistant Public Defenders, Daytona Beach, for Appellant.

Pamela Jo Bondi, Attorney General, Tallahassee, and Allison Leigh Morris, Assistant Attorney General, Daytona Beach, for Appellee.

PER CURIAM.

AFFIRMED.

ORFINGER, WALLIS and LAMBERT, JJ., concur.
Exhibit 32.2

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Total First Aid, Inc. (the
"Company") on Form 10-QSB for the quarter ended March 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Jeffrey
Tabin, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002,
that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.

/s/ Jeffrey Tabin
------------------
Jeffrey Tabin
Chief Financial Officer
May 13, 2004
Justin A. FRANCESCHI, Appellant, v. STATE of Florida, Appellee.

Case No. 5D18-3290

District Court of Appeal of Florida, Fifth District.

Opinion filed December 21, 2018

Justin A. Franceschi, Milton, pro se.

No Appearance for Appellee.

PER CURIAM.

Justin Franceschi appeals an order denying his motion to correct illegal sentence filed pursuant to Florida Rule of Criminal Procedure 3.800(a). In his motion, Franceschi raised three claims. The trial court properly denied Franceschi's first claim but failed to address claims two and three. Accordingly, we remand for the trial court to rule on these claims.

AFFIRMED, in part; REVERSED, in part; and REMANDED.

TORPY, EVANDER and EISNAUGLE, JJ., concur.
---

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS
ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Entourage Mining
Limited (the Company) on Form 20-F for the period ended December 31, 2007 as
filed with the Securities and Exchange Commission on the date hereof (the
Report), the undersigned, in the capacities and on the dates indicated below,
hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

|1. | The Report fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
  and                                   
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------
|   |                                                                                                                                                                 
|2. | The information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of the Company.







Date: June 30, 2008

/s/Gregory F.
KennedyGregory
F. Kennedy, President and C.E.O. (Principal Executive Officer)

---
QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 4.14    
    


(FORM OF STOCK CERTIFICATE-FRONT SIDE) 


SEE RESTRICTIVE LEGEND ON REVERSE SIDE 



	NUMBER	SHARES




INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE 


MERISANT WORLDWIDE, INC.  


This Certifies That
                                         
                                is the owner of
                                         
                                full paid and
non-assessable SHARES OF THE CLASS B COMMON STOCK of MERISANT WORLDWIDE, INC. transferable on the books of the Corporation in person or by duly authorized Attorney upon
surrender of this Certificate properly endorsed. 


In Witness Whereof, the said Corporation has caused this Certificate to be signed by its duly authorized officers and sealed with the Seal of the
Corporation, this                               day of
                              A.D.
               



	    
 Warren B. Grayson, Secretary	 	    
 Etienne J. Veber, President




(FORM OF STOCK CERTIFICATE-BACK SIDE) 


For Value Received,            hereby sell, assign and transfer unto
                                         
                               
Shares represented by the within Certificate, and do hereby irrevocably constitute and appoint
                              Attorney to transfer the said Shares on the books of the
within named Corporation with full power of substitution in the premises. 



	Dated	 	    
	 	 	 
	

 	
 	

In presence of	
 	

 	

 
	

    
	
 	

    
	

 






THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS IT HAS BEEN
REGISTERED UNDER SUCH ACT AND ALL SUCH APPLICABLE LAWS OR ANY EXEMPTION FROM REGISTRATION IS AVAILABLE. 


THE
SECURITIES REPRESENTED BY THIS CERTIFICATE MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE SECURITYHOLDER, A COPY OF WHICH IS ON FILE WITH THE
SECRETARY OF THE COMPANY. THE SALE, TRANSFER OR OTHER DISPOSITION OF THE SECURITIES IS SUBJECT TO THE TERMS OF SUCH AGREEMENT AND THE SECURITIES ARE TRANSFERABLE ONLY UPON PROOF OF COMPLIANCE
THEREWITH. 











QuickLinks



Exhibit 4.14
```

[Federal Register Volume 89, Number 244 (Thursday, December 19, 2024)]
[Notices]
[Page 103845]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30113]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Biomedical Imaging and Bioengineering; 
Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting of the 
National Institute of Biomedical Imaging and Bioengineering Special 
Emphasis Panel.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; P41 NCBIB Review D-SEP.
    Date: March 4-7, 2025.
    Time: 9:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Democracy II, Suite 920, 
6707 Democracy Blvd., Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: John Hayes, Ph.D., Scientific Review Officer, 
National Institute of Biomedical Imaging and Bioengineering, 
National Institutes of Health, 6707 Democracy Blvd., Bethesda, MD 
20892, (301) 451-3398, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, 
National Institute of Biomedical Imaging and Bioengineering, 
National Institutes of Health.)

    Dated: December 13, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-30113 Filed 12-18-24; 8:45 am]
BILLING CODE 4140-01-P
```
Jontavious K. GAINOUS, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D18-1277

District Court of Appeal of Florida, Second District.

January 04, 2019

BY ORDER OF THE COURT:

Pursuant to the notice of voluntary dismissal filed herein, this appeal is dismissed.
Alonzo M. HEARD, Appellant, v. STATE of Florida, Appellee.

Case No. 5D18-2906

District Court of Appeal of Florida, Fifth District.

Opinion filed December 18, 2018

Alonzo M. Heard, Defuniak Springs, pro se.

No Appearance for Appellee.

PER CURIAM.

AFFIRMED. *See**Chapman v. State*, 14 So.3d 273 (Fla. 5th DCA 2009).

ORFINGER, BERGER and HARRIS, JJ., concur.